Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | ARGX | INSM | ||
| Company | Alnylam Pharmaceuticals | Argenx Se ADR | Insmed Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 327.10 | 695.89 | 147.98 | ||
| High | 329.68 | 705.66 | 149.20 | ||
| Low | 316.85 | 690.85 | 142.59 | ||
| Latest | 317.36 | 691.40 | 145.30 | ||
| Change | -10.80 | -1.43 | -2.30 | ||
| % Change | -3.29% | -0.21% | -1.56% | ||
| Volume | 815,900 | 418,900 | 3,402,200 | ||
| 20-Day Average Volume | 1,170,680 | 356,435 | 2,336,230 | ||
| Previous Close | 328.16 | 692.83 | 147.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 318.78 | 710.23 | 143.39 | ||
| 20-Day Raw Stochastic | 50.98% | 28.32% | 65.82% | ||
| 20-Day Relative Strength | 43.92 | 36.48 | 46.99 | ||
| Weighted Alpha | +0.36 | +7.94 | +49.29 | ||
| Today's Opinion | 96% Sell | 72% Sell | 56% Sell | ||
| Previous Opinion | 80% Sell | 72% Sell | 56% Sell | ||
| Last Month's Opinion | 88% Sell | 8% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.66% since 03/20/26 | +4.14% since 03/20/26 | +6.84% since 03/20/26 | ||
| Low | 299.62 on 03/24/26 | 666.79 on 03/24/26 | 137.20 on 03/24/26 | ||
| High | 332.81 on 03/26/26 | 705.66 on 03/27/26 | 149.88 on 03/26/26 | ||
| 1-Month | |||||
| %Chg | -4.67% since 02/27/26 | -9.85% since 02/27/26 | -2.70% since 02/27/26 | ||
| Low | 299.62 on 03/24/26 | 661.85 on 03/20/26 | 135.73 on 03/20/26 | ||
| High | 334.42 on 03/02/26 | 766.19 on 03/02/26 | 150.27 on 03/04/26 | ||
| 3-Month | |||||
| %Chg | -20.78% since 12/26/25 | -18.17% since 12/26/25 | -18.32% since 12/26/25 | ||
| Low | 298.00 on 02/12/26 | 661.85 on 03/20/26 | 135.73 on 03/20/26 | ||
| High | 427.05 on 01/07/26 | 881.89 on 01/27/26 | 186.19 on 01/09/26 | ||
| 6-Month | |||||
| %Chg | -28.91% since 09/26/25 | -2.84% since 09/26/25 | +6.04% since 09/26/25 | ||
| Low | 298.00 on 02/12/26 | 661.85 on 03/20/26 | 135.73 on 03/20/26 | ||
| High | 495.55 on 10/20/25 | 934.62 on 12/03/25 | 212.75 on 12/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 42,089,236 | 42,785,900 | 31,319,708 | ||
| Shares Outstanding, K | 132,623 | 61,883 | 215,552 | ||
| Annual Sales | 3,713,940,000 | 4,248,050,000 | 606,420,000 | ||
| Annual Net Income | 313,750,000 | 1,292,040,000 | -1,276,780,000 | ||
| Last Quarter Sales | 1,097,030,000 | 1,322,160,000 | 263,840,000 | ||
| Last Quarter Net Income | 186,420,000 | 532,950,000 | -328,490,000 | ||
| 60-Month Beta | 0.36 | 0.38 | 1.13 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.25 on 02/12/26 | 8.02 on 02/26/26 | -1.54 on 02/19/26 | ||
| Latest Earnings Date | 05/07/26 | 05/14/26 | 05/14/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 193.04 | 35.49 | 0.00 | ||